Company Overview and News

2
CRM / Salesforce.com, Inc. PRE 14A

22h sec.gov
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2
Upvote Downvote

 
CRM / Salesforce.com, Inc. 425 (Prospectus)

2018-04-20 sec.gov
425 Filed by salesforce.com, inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: MuleSoft, Inc. (Commission File No. 001-38031)
Upvote Downvote

 
CRM / Salesforce.com, Inc. 425 (Prospectus)

2018-04-20 sec.gov
425 Filed by salesforce.com, inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: MuleSoft, Inc. (Commission File No. 001-38031)
Upvote Downvote

 
The Zacks Analyst Blog Highlights: salesforce.com, DXC Technology, Equity Bancshares, Myers Industries and Harsco

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include salesforce.com, inc. (CRM - Free Report) , DXC Technology Company (DXC - Free Report) , Equity Bancshares, Inc. (EQBK - Free Report) , Myers Industries, Inc.
Upvote Downvote

 
Billion-Dollar Unicorns: What Other MarTech Startups Will HubSpot Acquire Next?

2018-04-18 seekingalpha
I would like to know if it is looking at companies in regions such as India to add to its portfolio.
Upvote Downvote

 
Box Inc Stock Is a Cheap Way to Play the Cloud

2018-04-17 investorplace
While the cloud stocks have seen a tremendous bull move for a while, there are some operators that have missed out. Just look at Box Inc (NYSE:BOX). The company’s shares are about even for the year. In fact, during the past three years, the return for BOX stock is a measly 7% or so.
Upvote Downvote

 
5 Top Stocks to Gain as the Tax Season Draws to a Close

2018-04-17 zacks
There are many ‘calendar trends’ in the financial markets which indicate its outperformance or underperformance in a given time frame. The common axioms are“Sell in May and go away”, the “January Effect” and the “January Barometer”, to name a few.
Upvote Downvote

3
CRM / Salesforce.com, Inc. 425 (Prospectus)

2018-04-17 sec.gov
425 Filed by salesforce.com, inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: MuleSoft, Inc. (Commission File No. 001-38031)
Upvote Downvote

1
CRM / Salesforce.com, Inc. 425 (Prospectus)

2018-04-17 sec.gov
425 Filed by salesforce.com, inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: MuleSoft, Inc. (Commission File No. 001-38031)
Upvote Downvote

 
Profits and Growth Priced Into Adobe Systems Incorporated Stock

2018-04-16 investorplace
Adobe Systems Incorporated (NASDAQ:ADBE) has produced high returns for both long- and short-term investors recently. Its suite of Adobe Creative products has generated both user and investor interest. Also, its current management team, which recently announced a change, has led ADBE to outsized profit growth over the last few years.
Upvote Downvote

 
The Bull Case Keeps Getting Better for Cisco Systems, Inc. Stock

2018-04-16 investorplace
During the past few months, Cisco Systems, Inc. (NASDAQ:CSCO) certainly has been volatile, a has much of the tech sector. Just take a look at the charts for big-names like Facebook, Inc. (NASDAQ:FB), Amazon.com, Inc. (NASDAQ:AMZN) and Oracle Corporation (NYSE:ORCL). Yet Cisco stock has still been able to manage through all this fairly well.
Upvote Downvote

 
Venture Capital Deals Of The Week: Tencent Led $3B Investment

2018-04-14 seekingalpha
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
Upvote Downvote

1
SA Stock To Watch: Netflix To The Rescue?

2018-04-14 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

 
The Salesforce.com, Inc. Acquisition of Mulesoft is a Bigger Deal Than it May Seem

2018-04-13 investorplace
Mulesoft Inc (NYSE:MULE) isn’t exactly a household name. That may be why investors more or less shrugged their shoulders when they heard last month that salesforce.com, inc. (NYSE:CRM). And, for owners of Salesforce stock that know the details of the deal and what Mulesoft is, the $6.5 billion offer for the outfit is a bit of a jaw-dropper.
Upvote Downvote

 
American Airlines Is A Buy - Cramer's Lightning Round (4/12/18)

2018-04-13 seekingalpha
Cramer took a controversial view on Valeant, saying he would not be a seller at $16.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 79466L302